Download PDF
CC BY-NC-ND 4.0 · Ibnosina Journal of Medicine and Biomedical Sciences 2019; 11(04): 188-191
DOI: 10.4103/ijmbs.ijmbs_53_19
Case Report

Hepatitis A-associated cholestasis and aplastic anemia

Amal Elarabi
1   Department of Paediatric Gastroenterology and Hepatology, Tripoli University Hospital, Tripoli
,
Zinab Saad
1   Department of Paediatric Gastroenterology and Hepatology, Tripoli University Hospital, Tripoli
2   Department of Paediatric, Faculty of Medicine, University of Tripoli, Tripoli
,
Fauzi Sagher
1   Department of Paediatric Gastroenterology and Hepatology, Tripoli University Hospital, Tripoli
2   Department of Paediatric, Faculty of Medicine, University of Tripoli, Tripoli
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Hepatitis A virus (HAV) infection in children is typically an acute, self-limited illness associated with general, nonspecific symptoms. Prolonged cholestasis is a rare atypical form of HAV infection that is characterized by serum bilirubin levels higher than 10 mg/dl for more than 12 weeks. Aplastic anemia is another very rare complication of HAV. We report the case of an 11-year-old male with blood group O Rh positive who developed cholestasis followed by aplastic anemia postfulminant HAV infection. Liver function tests rapidly responded to a short course of steroid treatment. The patient had a sickle cell trait and a variant of ABCB11 gene. There was no history of traditional herbal treatment, but we noticed several cautery marks. Immunosuppressive medication was started for aplastic anemia, and he is listed for urgent bone marrow transplant. This is the first reported case of prolonged cholestasis followed by aplastic anemia complicating fulminant HAV infection in a Libyan adolescent.

Key-words:

Aplastic anemia - cholestasis - hepatitis A

Financial support and sponsorship

Nil.




Publication History

Received: 09 September 2019

Accepted: 12 November 2019

Article published online:
07 July 2022

© 2019. The Libyan Authority of Scientific Research and Technologyand the Libyan Biotechnology Research Center. All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License,permitting copying and reproductionso long as the original work is given appropriate credit. Contents may not be used for commercial purposes, oradapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Gebreel AO, Christie AB. Viral hepatitis in children: A study in Libya. Ann Trop Paediatr 1983;3:9-11.
  • 2 Blei AT. Hepatic encephalopathy. In: Bacon BR, O'Grady JG, editors. Comprehensive Hepatology. 2nd ed. Philadelphia: Elsevier Mosby; 2006. p. 169-76.
  • 3 Gökçe S, Çenesiz F, Özalp Akın E. Steroid treatment of protracted cholestatic hepatitis A in a child with β-thalassemia. Turk J Gastroenterol 2014;25 Suppl 1:278-9.
  • 4 Osugi Y, Yagasaki H, Sako M, Kosaka Y, Taga T, Ito T, et al. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica 2007;92:1687-90.
  • 5 Cengiz C, Turhan N, Yolcu OF, Yilmaz S. Hepatitis associated with aplastic anemia: Do CD8(+) kupffer cells have a role in the pathogenesis? Dig Dis Sci 2007;52:2438-43.
  • 6 Cariani E, Pelizzari AM, Rodella A, Gargiulo F, Imberti L, Manca N, et al. Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays. J Hepatol 2007;46:743-7.
  • 7 Pongtanakul B, Das PK, Charpentier K, Dror Y. Outcome of children with aplastic anemia treated with immunosuppressive therapy. Pediatr Blood Cancer 2008;50:52-7.
  • 8 Adachi Y, Yasui H, Yuasa H, Ishi Y, Imai K, Kato Y. Hepatitis B virus-associated aplastic anemia followed by myelodysplastic syndrome. Am J Med 2002;112:330-2.
  • 9 Bozkaya H, Yurdaydin C, Törüner M, Arat M, Bozdayi AM, Erekul S, et al. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: Potential role of lamivudine. Dig Dis Sci 2002;47:1782-5.
  • 10 Honkaniemi E, Gustafsson B, Fischler B, Nemeth A, Frost BM, Papadogiannakis N, et al. Acquired aplastic anaemia in seven children with severe hepatitis with or without liver failure. Acta Paediatr 2007;96:1660-4.
  • 11 Alsakkal M, Al-Khateeb M, Alhalaby M, Khouri L. Hepatitis-associated aplastic Anemia: A report of 3 cases associated with HAV. J Pediatr Hematol Oncol 2019;41:e164-6.
  • 12 Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R. Systematic review: Hepatitis-associated aplastic anaemia-a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther 2009;30:436-43.
  • 13 Locasciulli A, Bacigalupo A, Bruno B, Montante B, Marsh J, Tichelli A, et al. Hepatitis-associated aplastic anaemia: Epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party. Br J Haematol 2010;149:890-5.